tipranavir (tpv) Search Results


90
Enzo Biochem tipranavir (tpv
Tipranavir (Tpv, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tipranavir+%28tpv%29/pmc03147656-111-47-56?v=Enzo+Biochem
Average 90 stars, based on 1 article reviews
tipranavir (tpv - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
US Biological Life Sciences tipranavir tpv
Thermal stability of wild-type HIV-1 protease (PRWT) and lysozyme in the presence and absence of each compound using differential scanning fluorimetry (DSF). The relative fluorescence intensity was plotted at each temperature. Melting temperature (Tm) values were calculated from the top of the peak in the derivative plot. (A) Melting curves of PRWT in the presence and absence of selected FDA-approved PIs. Thermal stability curves with all the compounds shifted to higher temperatures than in the absence of each compound with Tm values ranging from 75.42 (amprenavir [APV]) to 83.08°C <t>(tipranavir</t> <t>[TPV]),</t> with a ΔTm value of 19.24°C to 26.90°C. (B) Melting curves of PRWT in the presence and absence of GRL-057-14, GRL-058-14, and GRL-059-14. The curve of DRV is shown as a reference. All three compounds significantly shifted the thermal stability curves to higher temperatures than in the absence of each compound. Their Tm values were much higher than those of all the FDA-approved PIs tested (A). (C) Melting curves of lysozyme in the presence and absence of GRL-057-14, GRL-058-14, GRL-059-14, and DRV. None of the PIs examined affected the thermal stability curves, indicating that all the PIs examined were highly specific to PRWT and had no significant interactions with lysozyme.
Tipranavir Tpv, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tipranavir+%28tpv%29/pmc06658756-384-4-9?v=US+Biological+Life+Sciences
Average 90 stars, based on 1 article reviews
tipranavir tpv - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ChemScene llc tipranavir (tpv)
Thermal stability of wild-type HIV-1 protease (PRWT) and lysozyme in the presence and absence of each compound using differential scanning fluorimetry (DSF). The relative fluorescence intensity was plotted at each temperature. Melting temperature (Tm) values were calculated from the top of the peak in the derivative plot. (A) Melting curves of PRWT in the presence and absence of selected FDA-approved PIs. Thermal stability curves with all the compounds shifted to higher temperatures than in the absence of each compound with Tm values ranging from 75.42 (amprenavir [APV]) to 83.08°C <t>(tipranavir</t> <t>[TPV]),</t> with a ΔTm value of 19.24°C to 26.90°C. (B) Melting curves of PRWT in the presence and absence of GRL-057-14, GRL-058-14, and GRL-059-14. The curve of DRV is shown as a reference. All three compounds significantly shifted the thermal stability curves to higher temperatures than in the absence of each compound. Their Tm values were much higher than those of all the FDA-approved PIs tested (A). (C) Melting curves of lysozyme in the presence and absence of GRL-057-14, GRL-058-14, GRL-059-14, and DRV. None of the PIs examined affected the thermal stability curves, indicating that all the PIs examined were highly specific to PRWT and had no significant interactions with lysozyme.
Tipranavir (Tpv), supplied by ChemScene llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tipranavir+%28tpv%29/10__1007_slash_s11696___019___00771___4-25-0-9?v=ChemScene+llc
Average 90 stars, based on 1 article reviews
tipranavir (tpv) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Thermal stability of wild-type HIV-1 protease (PRWT) and lysozyme in the presence and absence of each compound using differential scanning fluorimetry (DSF). The relative fluorescence intensity was plotted at each temperature. Melting temperature (Tm) values were calculated from the top of the peak in the derivative plot. (A) Melting curves of PRWT in the presence and absence of selected FDA-approved PIs. Thermal stability curves with all the compounds shifted to higher temperatures than in the absence of each compound with Tm values ranging from 75.42 (amprenavir [APV]) to 83.08°C (tipranavir [TPV]), with a ΔTm value of 19.24°C to 26.90°C. (B) Melting curves of PRWT in the presence and absence of GRL-057-14, GRL-058-14, and GRL-059-14. The curve of DRV is shown as a reference. All three compounds significantly shifted the thermal stability curves to higher temperatures than in the absence of each compound. Their Tm values were much higher than those of all the FDA-approved PIs tested (A). (C) Melting curves of lysozyme in the presence and absence of GRL-057-14, GRL-058-14, GRL-059-14, and DRV. None of the PIs examined affected the thermal stability curves, indicating that all the PIs examined were highly specific to PRWT and had no significant interactions with lysozyme.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Novel Protease Inhibitors Containing C-5-Modified bis -Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance

doi: 10.1128/AAC.00372-19

Figure Lengend Snippet: Thermal stability of wild-type HIV-1 protease (PRWT) and lysozyme in the presence and absence of each compound using differential scanning fluorimetry (DSF). The relative fluorescence intensity was plotted at each temperature. Melting temperature (Tm) values were calculated from the top of the peak in the derivative plot. (A) Melting curves of PRWT in the presence and absence of selected FDA-approved PIs. Thermal stability curves with all the compounds shifted to higher temperatures than in the absence of each compound with Tm values ranging from 75.42 (amprenavir [APV]) to 83.08°C (tipranavir [TPV]), with a ΔTm value of 19.24°C to 26.90°C. (B) Melting curves of PRWT in the presence and absence of GRL-057-14, GRL-058-14, and GRL-059-14. The curve of DRV is shown as a reference. All three compounds significantly shifted the thermal stability curves to higher temperatures than in the absence of each compound. Their Tm values were much higher than those of all the FDA-approved PIs tested (A). (C) Melting curves of lysozyme in the presence and absence of GRL-057-14, GRL-058-14, GRL-059-14, and DRV. None of the PIs examined affected the thermal stability curves, indicating that all the PIs examined were highly specific to PRWT and had no significant interactions with lysozyme.

Article Snippet: Indinavir sulfate (IDV) and tipranavir (TPV) were purchased from United States Biological (Swampscott, MA).

Techniques: Fluorescence